HOME >> BIOLOGY >> NEWS
Researchers identify genetic mutation that may alter tumor cell proliferation

Indianapolis, July 4, 2007 -- Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. The altered form of AKT1 appears to cause tumor cell proliferation and may play a role in making cells resistant to certain types of therapies. The findings are reported in an advance online publication (AOP) of the journal Nature.

The PI3-Kinase/AKT pathway is among the most commonly activated cellular pathways in human cancers and members of this pathway are among the most frequently targeted for new cancer drug discovery efforts. Activation of this pathway results in cancer cell growth and cell survival. Although AKT1 is central to pathway activation, its role in cancer has been that of an intermediary between mutated upstream regulatory proteins and downstream survival signaling proteins. This is the first evidence of direct mutation of AKT1 in human cancer tumors: it was discovered in clinical samples from cancer patients, yet has never been detected in cancer cell lines.

This discovery is a seminal finding in cancer biology that confirms AKT1 as an oncogene in breast, colorectal and ovarian cancer. The mutation alters the electrostatics of binding pocket in the pleckstrin homology domain, the portion of the enzyme that docks with phospholipids on the cell membrane, said Kerry L. Blanchard, PhD, MD, Executive Director, Discovery Biology Research, Eli Lilly & Company.

To identify the AKT1 mutation, the researchers analyzed 150 tumor samples from patients with either breast, colorectal or ovarian cancer (50 samples from each tumor type). Analysis of the data showed that 8 percent of breast, 6 percent of colorectal and 2 percent of ovarian tumors had the AKT1 mutation in the samples that were screened in their study.

Recently, molecular features such as the AKT1 mutation are
'"/>

Contact: Amy Erickson
aerickson@tgen.org
602-343-8522
The Translational Genomics Research Institute
4-Jul-2007


Page: 1 2 3

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers discover method for identifying how cancer evades the immune system
9. Researchers use adult stem cells to create soft tissue
10. Researchers find gene that spurs development of the epididymis
11. Researchers isolate new risk marker for overweight children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... Earthres ... the International Bottled Water Association’s (IBWA’s) IBWA/Shayron Barnes-Selby Advocacy Award at the IBWA ... named “The Selby” after longtime IBWA contributor Shayron Barnes-Selby, is awarded to an ...
(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new ... Divestopedia surveyed over 480 investment bankers and M&A advisors worldwide to compile the third ... insights on the key findings in the report. , Highlights in the 2018-19 ...
(Date:11/15/2018)... ... 2018 , ... uBiome, the leader in microbial genomics, announces ... Functional Medicine to its Medical Advisory Board. Joining the board of leading scientists ... experience in treating the root causes of disease, conscientiously taking into account nutritional, ...
Breaking Biology News(10 mins):
(Date:11/11/2018)... DIEGO (PRWEB) , ... November 09, 2018 , ... Triple ... a CES® 2019 Innovation Awards Honoree for DFree ®, the first ... notifies you when it’s time to go to the bathroom. The announcement was made ...
(Date:11/7/2018)... ... ... Diversified Technologies, Inc. (DTI) has installed a PEF (Pulsed Electric ... and Innovation at ASU. Funded by a USDA NIFA SBIR, the purpose of the ... predator control applications. , Algae ponds get up to 50% consumed by predators and ...
(Date:11/5/2018)... ... November 05, 2018 , ... ... 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research ... the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based ...
(Date:10/31/2018)... ... October 30, 2018 , ... Pippa Rose is a young Labrador retriever. Like most labs, ... suffered a partial tear to the cruciate ligament in her right knee. According to ... walks. Kinsley reported that it broke her heart to see Pippa lie around in ...
Breaking Biology Technology:
Cached News: